Skip to content

April 2026: Thirlwall Inquiry final report due after Easter · CCRC still reviewing 31+ independent expert reports · Shoo Lee Panel (Feb 2025): no medical evidence of deliberate harm.

Lucy Letby Facts

Biography · Inquiry counsel

Simon Medland KC

Senior barrister and King’s Counsel. Leading Counsel to the Thirlwall Inquiry for much of the examination of how the Countess of Chester executive team responded to consultants’ 2015–2017 concerns. His cross-examination of executives, regulators, and external reviewers is one of the principal sources of the documentary record the CCRC application now draws on.

Inquiry counsel
UK
Last updated
3 min read

Why his role matters

The Thirlwall Inquiry’s evidence record was not produced in a vacuum. It is the product of sustained cross-examination by Counsel to the Inquiry, who work under the chair’s direction to test and develop the record. Mr Medland KC’s examination of executives, HR, external reviewers, and regulatory figures is where the specific features of the institutional failure — the scope limits of the RCPCH review, the apology-letter sequence, the eight-month delay before police involvement — came onto the public record with documentary detail.

Professional background

  • Senior barrister, King’s Counsel.
  • Practice includes criminal law, public inquiries and regulatory matters.
  • Appointed Counsel to the Thirlwall Inquiry on its establishment in 2023.

What his examination has established

Across the 2024–2025 Inquiry hearings, Counsel to the Inquiry, including Mr Medland KC, established the following features of the institutional record:

  • The sequence and substance of the 2015 consultants’ concerns.
  • The RCPCH Invited Service Review’s scope and what its authors say about it.
  • The 2016 HR grievance sequence against the consultants.
  • The eight-month delay between the September 2016 consultants’ letter and the May 2017 police referral.
  • The role of executives and of the Director of Corporate Affairs (a former police officer) in shaping that delay.
  • The regulatory-oversight package (CQC, NHS Improvement) and its scope limits.

Read alongside